1. Home
  2. AIRE vs LPTX Comparison

AIRE vs LPTX Comparison

Compare AIRE & LPTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AIRE
  • LPTX
  • Stock Information
  • Founded
  • AIRE 2021
  • LPTX 2011
  • Country
  • AIRE United States
  • LPTX United States
  • Employees
  • AIRE N/A
  • LPTX N/A
  • Industry
  • AIRE
  • LPTX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • AIRE
  • LPTX Health Care
  • Exchange
  • AIRE Nasdaq
  • LPTX Nasdaq
  • Market Cap
  • AIRE 40.7M
  • LPTX 35.4M
  • IPO Year
  • AIRE N/A
  • LPTX N/A
  • Fundamental
  • Price
  • AIRE $0.53
  • LPTX $0.41
  • Analyst Decision
  • AIRE Hold
  • LPTX Hold
  • Analyst Count
  • AIRE 1
  • LPTX 1
  • Target Price
  • AIRE N/A
  • LPTX N/A
  • AVG Volume (30 Days)
  • AIRE 41.6M
  • LPTX 2.0M
  • Earning Date
  • AIRE 11-12-2025
  • LPTX 11-17-2025
  • Dividend Yield
  • AIRE N/A
  • LPTX N/A
  • EPS Growth
  • AIRE N/A
  • LPTX N/A
  • EPS
  • AIRE N/A
  • LPTX N/A
  • Revenue
  • AIRE $3,043,657.00
  • LPTX N/A
  • Revenue This Year
  • AIRE $410.32
  • LPTX N/A
  • Revenue Next Year
  • AIRE $166.28
  • LPTX N/A
  • P/E Ratio
  • AIRE N/A
  • LPTX N/A
  • Revenue Growth
  • AIRE 2973.28
  • LPTX N/A
  • 52 Week Low
  • AIRE $0.14
  • LPTX $0.22
  • 52 Week High
  • AIRE $4.49
  • LPTX $3.92
  • Technical
  • Relative Strength Index (RSI)
  • AIRE 45.11
  • LPTX 41.65
  • Support Level
  • AIRE $0.50
  • LPTX $0.43
  • Resistance Level
  • AIRE $0.93
  • LPTX $0.56
  • Average True Range (ATR)
  • AIRE 0.18
  • LPTX 0.06
  • MACD
  • AIRE -0.01
  • LPTX -0.02
  • Stochastic Oscillator
  • AIRE 15.46
  • LPTX 2.54

About AIRE reAlpha Tech Corp.

ReAlpha Tech Corp is a real estate technology company. The group is engaged in an end-to-end commission-free homebuying platform. It develops and utilizes its artificial intelligence-focused technology stack to empower retail investor participation in short-term rental properties, which are real estate units listed for a rental term. It provides short-term rental investment opportunities to everyday investors. The company has developed technologies and tools that allow for the analysis of short-term rental properties using AI to provide insight into that property's potential profitability and ways to increase such profitability. The company's reportable segments are; Platform Services and the Rental business segment.

About LPTX Leap Therapeutics Inc.

Leap Therapeutics Inc is a biopharmaceutical company developing novel biomarker-targeted antibody therapies designed to treat patients with cancer by inhibiting fundamental tumor-promoting pathways, targeting cancer-specific cell surface molecules, and harnessing the immune system to attack cancer cells. The company's key clinical-stage drug candidate is sirexatamab (DKN-01), which targets Dickkopf-related protein 1 (DKK1) and is being studied in a clinical trial in patients with colorectal cancer. In addition, it also has a preclinical program to develop a proprietary monoclonal antibody, called FL-501 which works by inhibiting the GDF-15 protein.

Share on Social Networks: